Literature DB >> 2792196

The effect of loxiglumide (CR-1505) on basal and bombesin-stimulated gallbladder volume in man.

B R Douglas1, M C Jebbink, R T Tjon a Tham, J B Jansen, C B Lamers.   

Abstract

This study was undertaken in 5 normal subjects to determine the role of cholecystokinin (CCK) in the regulation of basal gallbladder volume and gallbladder contraction stimulated by infusion of bombesin. Administration of the CCK-receptor antagonist, loxiglumide (CR-1505), led to doubling of the gallbladder volume (increase 104 +/- 26%; P less than 0.05) and reduced the bombesin-stimulated gallbladder contraction from 69 +/- 17 to 19 +/- 17% (P less than 0.05). The findings provide evidence suggesting that CCK plays an important role in the regulation of basal gallbladder tone and in mediating the gallbladder contraction induced by the administration of bombesin.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2792196     DOI: 10.1016/0014-2999(89)90073-3

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  6 in total

1.  Effect of loxiglumide (CR-1505) on bombesin- and meal-stimulated plasma cholecystokinin in man.

Authors:  J B Jansen; M C Jebbink; B R Douglas; C B Lamers
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

2.  Reducing serum cholesterol. Confusion remains over whom to treat.

Authors:  D F Weetman
Journal:  BMJ       Date:  1993-07-10

3.  Plasma cholecystokinin and gallbladder responses to increasing doses of bombesin in celiac disease.

Authors:  P W Thimister; W P Hopman; G Rosenbusch; J B Jansen
Journal:  Dig Dis Sci       Date:  1998-03       Impact factor: 3.199

4.  Gall bladder contractility in preterm infants.

Authors:  L Lehtonen; E Svedström; P Kero; H Korvenranta
Journal:  Arch Dis Child       Date:  1993-01       Impact factor: 3.791

5.  The size and contractility of the gallbladder in infants.

Authors:  L Lehtonen; E Svedström; H Korvenranta
Journal:  Pediatr Radiol       Date:  1992

6.  Lack of effect of the specific cholecystokinin receptor antagonist loxiglumide on cholecystokinin clearance from plasma in man.

Authors:  M C Jebbink; J B Jansen; A A Masclee; C B Lamers
Journal:  Br J Clin Pharmacol       Date:  1990-06       Impact factor: 4.335

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.